Ducol Organics And Colours Limited has announced the completion of Phase 1 of its acquisition of Xchem Polymers India Private Limited. The company has paid a cash consideration of ₹38 crore to acquire a 50.67% majority stake, becoming the majority shareholder. This transaction is the first phase of a proposed 100% acquisition, with the total deal valued at ₹75 crore. The Sale and Purchase Agreement (SPA) was signed on March 26, 2026.

Xchem Polymers India Private Limited, incorporated in 2010, is a debt-free company engaged in the development and manufacturing of high-performance construction chemicals and industrial adhesives. Its product portfolio includes waterproofing compounds, tile adhesives, repair mortars, sealants, and specialty coatings. The company operates a state-of-the-art manufacturing facility in Vapi, Gujarat, catering to the construction, real estate, and infrastructure sectors.

Strategic Rationale

This acquisition strengthens Ducol’s presence in the waterproofing and construction chemicals segments. Management highlighted that combining the Bitumag and Xchem ecosystems allows the company to serve the entire construction value chain more holistically. The move aligns with Ducol’s strategy of disciplined inorganic growth and portfolio diversification to enhance its competitive positioning in specialty chemicals.

Transaction Details

Ducol remains focused on executing this acquisition and unlocking growth opportunities in high-potential specialty chemical segments. The company continues to leverage its over 30 years of experience in product development and innovation to drive long-term value for stakeholders.

Ducol Organics And Colours Limited has received in-principle approval from the National Stock Exchange (NSE) to list 39,682 equity shares issued on a preferential basis. The approval, communicated on May 21, 2026, paves the way for these shares to be officially traded on the exchange following necessary confirmations from depositories.

Listing Approval Details

The NSE granted the approval for the listing of 39,682 equity shares of ₹10 each. These shares were allotted on a preferential issue basis to strategic investors. The shares bear distinctive numbers ranging from 16254277 to 16293958. The official communication from the exchange confirms that the shares will be listed and admitted to dealings upon receipt of confirmation from depositories, specifically NSDL and CDSL, regarding the credit of beneficiaries' accounts.

Regulatory Compliance

The company intimated the exchange regarding this development under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. The application for the in-principle approval was processed via the NEAPS Portal, with the approval letter downloaded by the company on May 22, 2026.

The following table summarizes the key details of the approval:

The confirmation from the depositories is the final procedural step required before the shares commence trading on the NSE.